When it comes to CLL/SLL treatment, what’s the difference between BTK inhibitors and BCL-2 inhibitors? Understanding how these treatment approaches work and how they fit into the treatment…
BTK degrader BGB-16673 reduced tumor burden in 85% of patients from a high-risk, hard-to-treat group with relapsed / refractory CLL. Dr. Stephan Stilgenbauer from Ulm University and colleagues…
NEW YORK (Reuters Health) – Surgery appears to be safe option in treatment of certain elderly patients with renal tumors, German researchers report in the September issue of…
NEW YORK (Reuters Health) – Implementation of a breast cancer screening program has a “profound impact” on breast cancer mortality, according to a study in the Netherlands. “About…
NEW YORK (Reuters Health) – New research suggests that older patients with advanced renal cell carcinoma glean as much benefit from sorafenib as do their younger counterparts. Moreover,…
NEW YORK (Reuters Health) – In men, the risk of developing breast cancer is increased by having a first-degree relative with breast cancer, being obese and physically inactive,…
Douglas S. Hawkins, MD, Associate Professor, Pediatrics, Seattle Children’s Hospital, Seattle WA, discusses errors with orally administered chemotherapy medication in children. References and Resources Taylor JA, Winter L,…
NEW YORK (Reuters Health) – Detection of JC virus, an important cause of progressive multifocal leukoencephalopathy (PML) in immunosuppressed patients, is not a good predictor of PML risk…
Dr. Susan Love discusses her partnership with the Avon Foundation and the origins of the “Army of Women” fighting to prevent and cure breast cancer. References and Resources…
NEW YORK (Reuters Health) – High-dose therapy (HDT) combined with autologous stem cell transplantation (ASCT) may prolong remissions and improve survival in patients with chemoresistant Hodgkin lymphoma, researchers…
NEW YORK (Reuters Health) – In evaluating screening mammograms for breast cancer, a single reader with computer assistance can perform just as well as two readers, the results…
NEW YORK (Reuters Health) – The results of a new study indicate that 80% of cancer patients undergoing radiation therapy do not use medications to combat pain. Many…
